Melanoma Clinical Trial

Clinical Trial Finder Melanoma Trials

Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma

See Locations Near You

Summary

This research is being done to find out the safety of MORAb-028 in subjects with metastatic melanoma.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically confirmed AJCC Stage IIIB, IIIC or IV melanoma with injectable metastases (in transit, intradermal, or subcutaneous nodules)
Tumor accessible to intra-tumoral injections
Cumulative tumor volume great enough to accept MORAb-028 injections for a given dose level, based on intent to inject at a concentration of 1 mg/cm3

Exclusion Criteria:

Are candidates for curative surgical excision or lymphadenectomy
Prior non-surgical treatment within 4 weeks
Known central nervous system (CNS) tumor involvement or metastases
Hypersensitivity to MORAb-028

Study is for people with:

Melanoma

Phase:

Phase 1

Estimated Enrollment:

18

Study ID:

NCT01123304

Recruitment Status:

Terminated

Sponsor:

Morphotek

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

John Wayne Cancer Institute
Santa Monica California, 90404, United States

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Phase:

Phase 1

Estimated Enrollment:

18

Study ID:

NCT01123304

Recruitment Status:

Terminated

Sponsor:


Morphotek

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider